Amundi Asset Management US’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$6.59M Buy
50,494
+6,902
+16% +$831K 0.01% 945
2020
Q4
$4.88M Buy
43,592
+8,168
+23% +$773K ﹤0.01% 978
2020
Q3
$2.79M Buy
35,424
+9,594
+37% +$782K ﹤0.01% 1026
2020
Q2
$1.86M Sell
25,830
-5,370
-17% -$374K ﹤0.01% 1090
2020
Q1
$1.79M Buy
31,200
+4,904
+19% +$452K ﹤0.01% 984
2019
Q4
$2.94M Buy
26,296
+23,996
+1,043% +$2.56M ﹤0.01% 1048
2019
Q3
$221K Buy
2,300
+500
+28% +$46.9K ﹤0.01% 1437
2019
Q2
$154K Hold
1,800
﹤0.01% 1514
2019
Q1
$150K Buy
+1,800
New +$131K ﹤0.01% 1489

Other funds holding CNMD

Amundi Asset Management US's CNMD Position: Q1 2021 in Review

Amundi Asset Management US increased its CONMED (CNMD) stake by 16% in Q1 2021, buying an estimated $831K and bringing the position to 50,494 shares worth $6.59M. The position accounts for 0.01% of the portfolio, ranked #945.

Amundi Asset Management US first reported a position in CNMD in Q1 2019 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold CNMD as of Q1 2021.

  • Amundi Asset Management US held 50,494 shares of CONMED worth $6.59M as of Q1 2021.
  • Amundi Asset Management US bought 6,902 CONMED shares in Q1 2021, an estimated $831K.
  • CONMED made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #945 holding.
  • Amundi Asset Management US first reported a position in CONMED in Q1 2019 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held CONMED as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.